Skip to main content

Table 4 Sensitivities and specificities

From: Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism

Follow-up diagnosis

Sensitivity (95% CI)

Specificity (95% CI)

Positive predictive value (95% CI)

Negative predictive value (95% CI)

AP

0.82 (0.73–0.88)

0.79 (0.63–0.88)

0.91 (0.85–0.95)

0.61 (0.51–0.70)

MSA

1.00 (0.83–1.00)

0.91 (0.85–0.95)

0.62 (0.49–0.74)

1.00 (0.97–1.00)

DLB/PDD

0.81 (0.61–0.93)

0.97 (0.92–0.99)

0.84 (0.66–0.93)

0.96 (0.92–0.98)

4R-tauopathies (CBD/PSP)

0.62 (0.49–0.73)

0.97 (0.90–0.99)

0.93 (0.82–0.99)

0.77 (0.71–0.82)

NON-AP

0.79 (0.63–0.88)

0.82 (0.73–0.88)

0.61 (0.51–0.70)

0.91 (0.85–0.95)

  1. AP, atypical parkinsonism; MSA, multiple system atrophy; DLB/PDD, Dementia with Lewy bodies/Parkinson’s disease with dementia; CBD, corticobasal degeneration; PSP, progressive supranuclear palsy